
Opinion|Videos|August 20, 2024
Key Takeaways for Biosimilar Utilization
The panelists provide their closing thoughts, highlighting key considerations around biosimilar.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Thanks to all of you for this rich and informative discussion. Before we conclude I’d like to get final thoughts from each of you…
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
3
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
4
MDS/MPN Response Criteria Tied to Survival
5



